The American Journal of Hematology in 2007
Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States
Sickle cell bone disease: Response to vitamin D and calcium
Association between myeloid malignancies and acquired deficit in protein 4.1R: A retrospective analysis of six patients
Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients
Constitutive neutrophil apoptosis: Mechanisms and regulation
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors
Thrombocytopenia
Historical hematology: May-Hegglin anomaly
Reticulocyte hemoglobin content
RETICULOCYTE HEMOGLOBIN CONTENT SUMMARY TABLE
A 69-year-old male presenting with hypotension and anasarca
Potential of dendritic cell immunotherapy for relapse after allogeneic hematopoietic stem cell transplantation, shown by WT1 peptide- and keyhole limpet hemocyanin-pulsed, donor-derived dendritic cell vaccine for acute myeloid leukemia
Treatment of acquired factor × inhibitor by plasma exchange with concomitant intravenous immunoglobulin and corticosteroids
Severe aplastic anemia with hot pockets following daily Ecstasy ingestion
Fatal case of bilateral internal jugular vein thrombosis following IVIg infusion in an adolescent girl treated for ITP
Flow cytometry in the diagnosis of drug-induced thrombocytopenia: Two illustrative cases
Post-transplant hepatosplenic T-cell lymphoma successfully treated with HyperCVAD regimen
A multicenter retrospective study defining the clinical and hematological manifestations of brucellosis and pancytopenia in a large series: Hematological malignancies, the unusual cause of pancytopenia in patients with brucellosis
Granulocytic sarcoma with massive scalp involvement
Crypt loss, pericapillary hemorrhage, and severe gastrointestinal graft-versus-host disease
Stroke in thalassemia: A dilemma
Refractory idiopathic thrombocytopenic purpura treated with the soluble tumor necrosis factor receptor etanercept
Use of prothrombin complex concentrates in anticoagulation
Etanercept therapy and acute myeloid leukemia
TNF alpha inhibition and AML